Nefazodone. A review of its pharmacology and clinical efficacy in the management of major depression (Q34421296)

2 August 2017

1 reference

title

Nefazodone. A review of its pharmacology and clinical efficacy in the management of major depression (English)

1 reference

2 August 2017

1 reference

Davis R

1

1 reference

2 August 2017

Whittington R

series ordinal

2

1 reference

2 August 2017

Bryson HM

series ordinal

3

1 reference

2 August 2017

1 April 1997

1 reference

2 August 2017

1 reference

2 August 2017

53

1 reference

2 August 2017

4

1 reference

2 August 2017

608-636

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199753040-00006

2 August 2017

0 references

cites work

Expanding psychopharmacologic treatment options for the depressed medical patient

1 reference

12 December 2020

Pharmacology and neurochemistry of nefazodone, a novel antidepressant drug

1 reference

12 December 2020

Research diagnostic criteria: rationale and reliability

1 reference

12 December 2020

A Multicenter, Double-Blind Comparison of the Effects of Nefazodone and Fluoxetine on Sleep Architecture and Quality of Sleep in Depressed Outpatients

1 reference

12 December 2020

Single- and multiple-dose pharmacokinetics of nefazodone in patients with hepatic cirrhosis

1 reference

12 December 2020

The acute effects of nefazodone, trazodone and buspirone on sleep and sleep-related penile tumescence in normal subjects.

1 reference

12 December 2020

Comparison of growth hormone and prolactin stimulation induced by chlorimipramine and desimipramine in man in connection with chlorimipramine metabolism

1 reference

12 December 2020

Apparent interaction between nefazodone and cyclosporine

1 reference

12 December 2020

The effects of nefazodone on sleep architecture in depression

1 reference

12 December 2020

The effects of paroxetine and nefazodone on sleep: a placebo controlled trial

1 reference

12 December 2020

The lack effect of food on the bioavailability of nefazodone tablets.

1 reference

12 December 2020

Placebo-controlled dose-ranging trial designs in phase II development of nefazodone

1 reference

12 December 2020

Pharmacokinetics, absolute bioavailability, and disposition of [14C]nefazodone in humans

1 reference

12 December 2020

Attenuation of the prolactin-stimulating and hyperthermic effects of nefazodone after subacute treatment

1 reference

12 December 2020

Lack of interaction between nefazodone and cimetidine: a steady state pharmacokinetic study in humans

1 reference

12 December 2020

Nefazodone--a novel antidepressant--may increase REM sleep

1 reference

12 December 2020

Metabolism of drugs by cytochrome P450 3A isoforms. Implications for drug interactions in psychopharmacology.

1 reference

12 December 2020

Coadministration of nefazodone and benzodiazepines: IV. A pharmacokinetic interaction study with lorazepam

1 reference

12 December 2020

Antidepressants in long-term treatment

1 reference

12 December 2020

Nefazodone: a new antidepressant

1 reference

12 December 2020

Assessment of pharmacokinetic and pharmacodynamic drug interactions between nefazodone and digoxin in healthy male volunteers

1 reference

12 December 2020

Nefazodone-induced carbamazepine toxicity

1 reference

12 December 2020

Economic analysis of treating depression with nefazodone v. imipramine.

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic evaluation of warfarin and nefazodone coadministration in healthy subjects

1 reference

12 December 2020

Steady-state pharmacokinetics of nefazodone in subjects with normal and impaired renal function

1 reference

12 December 2020

Drug effects on REM sleep and on endogenous depression

1 reference

12 December 2020

Neuroendocrine and temperature effects of nefazodone in healthy volunteers.

1 reference

12 December 2020

1-(m-chlorophenyl)piperazine (mCPP) interactions with neurotransmitter receptors in the human brain.

1 reference

12 December 2020

Nefazodone pharmacokinetics: assessment of nonlinearity, intra-subject variability and time to attain steady-state plasma concentrations after dose escalation and de-escalation

1 reference

12 December 2020

Single and multiple dose pharmacokinetics of nefazodone in subjects classified as extensive and poor metabolizers of dextromethorphan

1 reference

12 December 2020

Controlled comparison of nefazodone and amitriptyline in major depressive inpatients

1 reference

12 December 2020

Nonlinear pharmacokinetics of nefazodone after escalating single and multiple oral doses

1 reference

12 December 2020

The treatment of depression: prescribing patterns of antidepressants in primary care in the UK

1 reference

12 December 2020

Nefazodone: preclinical pharmacology of a new antidepressant

1 reference

12 December 2020

Modelling the cost effectiveness of antidepressant treatment in primary care

1 reference

12 December 2020

Evaluation of nefazodone self-administration in rhesus monkeys

1 reference

12 December 2020

Long-term treatment of depression with nefazodone

1 reference

12 December 2020

Comparison of the steady-state pharmacokinetics of nefazodone after administration of 200 mg twice daily or 400 mg once daily in the morning or evening

1 reference

12 December 2020

Coadministration of nefazodone and benzodiazepines: I. Pharmacodynamic assessment.

1 reference

12 December 2020

Detection of depressive disorder for patients receiving prepaid or fee-for-service care. Results from the Medical Outcomes Study

1 reference

12 December 2020

Comparison of the tolerability of bupropion, fluoxetine, imipramine, nefazodone, paroxetine, sertraline, and venlafaxine.

1 reference

12 December 2020

Tolerability and safety: essentials in antidepressant pharmacotherapy

1 reference

12 December 2020

Response of anxiety and agitation symptoms during nefazodone treatment of major depression

1 reference

12 December 2020

Methodology for measuring health-state preferences--III: Population and context effects

1 reference

12 December 2020

A multicenter double-blind comparison of nefazodone and paroxetine in the treatment of outpatients with moderate-to-severe depression

1 reference

12 December 2020

The use of decision analysis in the pharmacoeconomic evaluation of an antidepressant: a cost-effectiveness study of nefazodone

1 reference

12 December 2020

Debits and credits in the management of depression.

1 reference

12 December 2020

Antidepressant drug interactions and the cytochrome P450 system. The role of cytochrome P450 2D6.

1 reference

12 December 2020

Nefazodone: aspects of efficacy

1 reference

12 December 2020

Nefazodone versus sertraline in outpatients with major depression: focus on efficacy, tolerability, and effects on sexual function and satisfaction

1 reference

12 December 2020

The serotonergic antidepressant nefazodone inhibits the serotonin transporter: in vivo and ex vivo studies

1 reference

12 December 2020

Trazodone associated with priapism

1 reference

12 December 2020

Acute and subchronic effects of nefazodone and imipramine on highway driving, cognitive functions, and daytime sleepiness in healthy adult and elderly subjects.

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic evaluation during coadministration of nefazodone and propranolol in healthy men.

1 reference

12 December 2020

Single-dose pharmacokinetics of nefazodone in healthy young and elderly subjects and in subjects with renal or hepatic impairment

1 reference

12 December 2020

Nefazodone in the treatment of severe, melancholic, and recurrent depression

1 reference

12 December 2020

Therapeutic dose range of nefazodone in the treatment of major depression

1 reference

12 December 2020

Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes.

1 reference

12 December 2020

Responders to antidepressant drug treatment: a study comparing nefazodone, imipramine, and placebo in patients with major depression

1 reference

12 December 2020

Serotonin receptor subtypes involved in the elevation of serum corticosterone concentration in rats by direct- and indirect-acting serotonin agonists

1 reference

12 December 2020

Managing selective serotonin reuptake inhibitor-drug interactions in clinical practice

1 reference

12 December 2020

Guidelines for the long-term treatment of depression.

1 reference

12 December 2020

The effects of nefazodone, imipramine and placebo, alone and combined with alcohol, in normal subjects

1 reference

12 December 2020

Reliability and validity of a health-related quality of life battery for evaluating outpatient antidepressant treatment

1 reference

12 December 2020

Investigation of pharmacokinetic and pharmacodynamic interactions after coadministration of nefazodone and haloperidol

1 reference

12 December 2020

Long-term treatments of recurrent depressive disorders

1 reference

12 December 2020

Effects of psychotropic drugs (desimipramine, chlorimipramine, sulpiride and diazepam) on the human HPA axis.

1 reference

12 December 2020

Coadministration of nefazodone and benzodiazepines: III. A pharmacokinetic interaction study with alprazolam

1 reference

12 December 2020

Epidemiology of depression in primary care

1 reference

12 December 2020

Evaluation of nefazodone as a serotonin uptake inhibitor and a serotonin antagonist in vivo.

1 reference

12 December 2020

A study of the effect of age and gender on the pharmacokinetics of nefazodone after single and multiple doses

1 reference

12 December 2020

Coadministration of nefazodone and benzodiazepines: II. A pharmacokinetic interaction study with triazolam

1 reference

12 December 2020

The safety profile of nefazodone

1 reference

12 December 2020

Depression: a neglected major illness.

1 reference

12 December 2020

High-performance liquid chromatographic method for the determination of nefazodone and its metabolites in human plasma using laboratory robotics

1 reference

12 December 2020

What price depression? The cost of depression and the cost-effectiveness of pharmacological treatment

1 reference

12 December 2020

Influence of hepatic impairment on the pharmacokinetics of nefazodone and two of its metabolites after single and multiple oral doses

1 reference

12 December 2020

Sleep research in affective illness: state of the art circa 1987.

1 reference

12 December 2020

Depression in the community: findings from the Stirling County Study

1 reference

12 December 2020

A double-blind comparison of nefazodone, imipramine, and placebo in major depression

1 reference

12 December 2020

Nefazodone and imipramine in major depression: a placebo-controlled trial

1 reference

12 December 2020

Diagnosis and treatment of depression in general practice

1 reference

12 December 2020

The prevalence and distribution of major depression in a national community sample: the National Comorbidity Survey

1 reference

12 December 2020

Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter.

1 reference

12 December 2020

Lack of an effect of nefazodone on the pharmacokinetics and pharmacodynamics of theophylline during concurrent administration in patients with chronic obstructive pulmonary disease

1 reference

12 December 2020

Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder.

1 reference

12 December 2020

A double-blind, placebo-controlled trial of two dose ranges of nefazodone in the treatment of depressed outpatients

1 reference

12 December 2020

The economic burden of depression in 1990.

1 reference

12 December 2020

10.2165/00003495-199753040-00006

Identifiers

DOI

1 reference

Dimensions Publication ID

2 August 2017

0 references

1 reference